Logo image of ALSA

ALPHA STAR ACQUISITION CORP (ALSA) Stock Fundamental Analysis

NASDAQ:ALSA - Nasdaq - KYG0230C1087 - Common Stock - Currency: USD

12.06  -0.14 (-1.15%)

Fundamental Rating

1

We assign a fundamental rating of 1 out of 10 to ALSA. ALSA was compared to 0 industry peers in the Unkown industry. ALSA has a bad profitability rating. Also its financial health evaluation is rather negative. ALSA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ALSA had positive earnings in the past year.
ALSA had a negative operating cash flow in the past year.
ALSA Yearly Net Income VS EBIT VS OCF VS FCFALSA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 1M 2M 3M 4M

1.2 Ratios

Industry RankSector Rank
ROA 2.49%
ROE 2.73%
ROIC N/A
ROA(3y)1.91%
ROA(5y)N/A
ROE(3y)2.08%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALSA Yearly ROA, ROE, ROICALSA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 1 2 3 4 5

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ALSA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ALSA Yearly Profit, Operating, Gross MarginsALSA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

2

2. Health

2.1 Basic Checks

ALSA has less shares outstanding than it did 1 year ago.
The debt/assets ratio for ALSA is higher compared to a year ago.
ALSA Yearly Shares OutstandingALSA Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M
ALSA Yearly Total Debt VS Total AssetsALSA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 20M 40M 60M 80M 100M

2.2 Solvency

An Altman-Z score of 3.05 indicates that ALSA is not in any danger for bankruptcy at the moment.
A Debt/Equity ratio of 0.06 indicates that ALSA is not too dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Altman-Z 3.05
ROIC/WACCN/A
WACCN/A
ALSA Yearly LT Debt VS Equity VS FCFALSA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 20M 40M 60M 80M 100M

2.3 Liquidity

ALSA has a Current Ratio of 0.00. This is a bad value and indicates that ALSA is not financially healthy enough and could expect problems in meeting its short term obligations.
A Quick Ratio of 0.00 indicates that ALSA may have some problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 0
Quick Ratio 0
ALSA Yearly Current Assets VS Current LiabilitesALSA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for ALSA have decreased strongly by -29.73% in the last year.
EPS 1Y (TTM)-29.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-130.22%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ALSA Yearly Revenue VS EstimatesALSA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023
ALSA Yearly EPS VS EstimatesALSA Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 52.43 indicates a quite expensive valuation of ALSA.
The average S&P500 Price/Earnings ratio is at 29.63. ALSA is valued rather expensively when compared to this.
Industry RankSector Rank
PE 52.43
Fwd PE N/A
ALSA Price Earnings VS Forward Price EarningsALSA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALSA Per share dataALSA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALSA!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ALPHA STAR ACQUISITION CORP

NASDAQ:ALSA (12/20/2024, 8:00:00 PM)

12.06

-0.14 (-1.15%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners111.33%
Inst Owner Change-98.72%
Ins OwnersN/A
Ins Owner Change0%
Market Cap49.57M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 52.43
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.54
P/tB 0.54
EV/EBITDA N/A
EPS(TTM)0.23
EY1.91%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS22.52
TBVpS22.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 2.49%
ROE 2.73%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)1.91%
ROA(5y)N/A
ROE(3y)2.08%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.06
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0
Quick Ratio 0
Altman-Z 3.05
F-Score5
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-130.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-113.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y85.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y85.99%
OCF growth 3YN/A
OCF growth 5YN/A